Page last updated: 2024-11-10

sinapaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sinapyl aldehyde: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(E)-sinapaldehyde : A member of the class of cinnamaldehydes that is cinnamaldehyde substituted by a hydroxy group at position 4 and methoxy groups at positions 3 and 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Senragenus[no description available]MalvaceaeThe mallow family of the order MALVALES, subclass Dilleniidae, class Magnoliopsida. The common names of hollyhock and mallow are used for several genera of Malvaceae.[MeSH]

Cross-References

ID SourceID
PubMed CID5280802
CHEMBL ID225067
CHEBI ID27949
SCHEMBL ID197270
MeSH IDM0203164

Synonyms (55)

Synonym
(2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enal
(e)-sinapaldehyde
(e)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-propenal
sinapyl aldehyde
(e)-sinapoyl aldehyde
CHEBI:27949 ,
(2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylaldehyde
(e)-sinapoaldehyde
(2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-propenal
3,5-dimethoxy-4-hydroxycinnamaldehyde
ACON1_001103
4206-58-0
sinapoyl aldehyde
C05610
sinapaldehyde ,
MEGXP0_001085
trans-3,5-dimethoxy-4-hydroxycinnamaldehyde, 98%
sinapinaldehyde
NCGC00169673-01
072ADBB5-241A-428F-B856-9EF1F076A5A6
CHEMBL225067
BRD-K19027245-001-01-0
BMSE000606
BMSE010085
3,4-dimethoxy-4-hydroxycinnamaldehyde
sny ,
3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enal
(e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enal
3,5 dimethoxy-4-hydroxycinnamaldehyde
unii-4vb87uv6wg
2-propenal, 3-(4-hydroxy-3,5-dimethoxyphenyl)-, (e)-
4vb87uv6wg ,
2-propenal, 3-(4-hydroxy-3,5-dimethoxyphenyl)-, (2e)-
3,5-dimethoxy-4-hydroxycinnamaldehyde (e)
AKOS015999009
(e)-3-(4-hydroxy-3,5-dimethoxy-phenyl)prop-2-enal
sinapic aldehyde
trans-3,5-dimethoxy-4-hydroxycinnamaldehyde
trans-3,5-dimethoxy-4-hydroxy cinnamaldehyde
SCHEMBL197270
CDICDSOGTRCHMG-ONEGZZNKSA-N
trans-sinapaldehyde
cinnamaldehyde, 4-hydroxy-3,5-dimethoxy-
retention index: see j. agric. food chem. 2009, 57, 3217-3227
(e)-3,5-dimethoxy-4-hydroxyphenylpropenaldehyde
20649-43-8
(e)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylaldehyde
mfcd00075980
EN300-1860016
Q63392287
DTXSID10863340
CS-0016716
HY-N1312
BS-42317
3-(4-hydroxy-3,5-dimethoxyphenyl)-2-propenal

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
cinnamaldehydesAn enal based on a cinnamaldehyde skeleton and its substituted derivatives.
dimethoxybenzeneAny methoxybenzene that consists of a benzene skeleton substituted with two methoxy groups and its derivatives.
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
monolignol glucosides biosynthesis111
phenylpropanoid biosynthesis1628
ferulate and sinapate biosynthesis013
ferulate and sinapate biosynthesis112
phenylpropanoid biosynthesis1229
Lignin biosynthesis221

Bioassays (10)

Assay IDTitleYearJournalArticle
AID607599Cytostatic activity against human U373 cells assessed as growth inhibition at MTT assay-related IC50 by quantitative video microscopy relative to control2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID282835Cytotoxicity against mouse L1210 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID607593Cytotoxicity against human U373 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID607600Induction of human U373 cell death assessed as morphological changes at MTT assay-related IC50 after 72 hrs by quantitative video microscopy2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID282834Activity against caspase-mediated apoptosis in mouse L1210 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID607596Cytotoxicity against human PC3 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID607595Cytotoxicity against human A549 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID607594Cytotoxicity against human OE21 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID607597Cytotoxicity against human SK-MEL-28 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID607598Cytotoxicity against human LoVo cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (4.17)18.2507
2000's10 (41.67)29.6817
2010's12 (50.00)24.3611
2020's1 (4.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.44 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index5.51 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]